One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dialysis, Transplantation, and Work
Stephen Z. Fadem
doi : 10.2215/CJN.09840822
October 2022; Volume 17,Issue 10
Palliative Care for Hemodialysis Patients?
Frank Brennan and Mark A. Brown
doi : 10.2215/CJN.09710822
Resistant Hypertension in Chronic Kidney Disease
Rachel Shulman and Jordana B. Cohen
doi : 10.2215/CJN.09720822
Reducing Racial Disparities in Access to Transplant in the United States
Rhiannon D. Reed and Jayme E. Locke
doi : 10.2215/CJN.09590822
Incorporating Training in POCUS in Nephrology Fellowship Curriculum
Nathaniel C. Reisinger and Abhilash Koratala
doi : 10.2215/CJN.09580822
The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography
Qandeel H. Soomro, Sonia T. Anand, Steven D. Weisbord, Martin P. Gallagher, Ryan E. Ferguson, Paul M. Palevsky, Deepak L. Bhatt, Chirag R. Parikh and James S. Kaufman; for the PRESERVE Trial Investigators
doi : 10.2215/CJN.02160222
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems
Jaejin An, Manjula Kurella Tamura, Michelle C. Odden, Liang Ni, I-Chun Thomas, Maria E. Montez-Rath and John J. Sim
doi : 10.2215/CJN.04110422
Arterial Stiffness and Chronic Kidney Disease Progression in Children
Karolis Azukaitis, Marietta Kirchner, Anke Doyon, Mieczysław Litwin, Aysun Bayazit, Ali Duzova, Nur Canpolat, Augustina Jankauskiene, Rukshana Shroff, Anette Melk, Uwe Querfeld and Franz Schaefer; on behalf of the 4C Study Investigators
doi : 10.2215/CJN.02200222
Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression
Titilayo O. Ilori, Jing Liu, Aylin R. Rodan, Ashish Verma, Katherine T. Mills, Jiang He, Cheryl A. Winkler, Josée Dupuis, Cheryl A.M. Anderson and Sushrut S. Waikar
doi : 10.2215/CJN.02680322
Point-of-Care Ultrasound Training during Nephrology Fellowship
Catherine A. Moore, Daniel W. Ross, Kurtis A. Pivert, Valerie J. Lang, Stephen M. Sozio and W. Charles O’Neill
doi : 10.2215/CJN.01850222
Implementation and Effectiveness of a Learning Collaborative to Improve Palliative Care for Seriously Ill Hemodialysis Patients
Manjula Kurella Tamura, Laura Holdsworth, Margaret Stedman, Annette Aldous, Steven M. Asch, Jialin Han, Glenda Harbert, Karl A. Lorenz, Elizabeth Malcolm, Amanda Nicklas, Alvin H. Moss and Dale E. Lupu
doi : 10.2215/CJN.00090122
Employment Status and Work Functioning among Kidney Transplant Recipients
Tim J. Knobbe, Daan Kremer, Femke I. Abma, Coby Annema, Stefan P. Berger, Gerjan J. Navis, Sijrike F. van der Mei, Ute Bültmann, Annemieke Visser and Stephan J.L. Bakker; on behalf of the TransplantLines Investigators
doi : 10.2215/CJN.05560522
Comparison of 2021 CKD-EPI Equations for Estimating Racial Differences in Preemptive Waitlisting for Kidney Transplantation
Elaine Ku, Sandra Amaral, Charles E. McCulloch, Deborah B. Adey, Libo Li and Kirsten L. Johansen
doi : 10.2215/CJN.04850422
Genome-Wide Epistatic Interaction between DEF1B and APOL1 High-Risk Genotypes for Chronic Kidney Disease
Ha My T. Vy, Bridget M. Lin, Faris F. Gulamali, Charles Kooperberg, Mariaelisa Graff, Jenny Wong, Kirk N. Campbell, Tara C. Matise, Josef Coresh, Fridtjof Thomas, Alexander P. Reiner, Rami Nassir, Peter F. Schnatz, Tanya Johns, Steven Buyske, Christopher Haiman, Richard Cooper, Ruth J.F. Loos, Carol R. Horowitz, Orlando M. Gutierrez, Ron Do, Nora Franceschini and Girish N. Nadkarni
doi : 10.2215/CJN.03610322
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings
Eric D. Weinhandl, Jiannong Liu, David T. Gilbertson, James B. Wetmore and Kirsten L. Johansen
doi : 10.2215/CJN.03400322
Postoperative Acute Kidney Injury
Naomi Boyer, Jack Eldridge, John R. Prowle and Lui G. Forni
doi : 10.2215/CJN.16541221
Rituximab in the Frail and Elderly with Severe ANCA-Associated GN
Silke R. Brix and Vladimir TesaÅ™
doi : 10.2215/CJN.04760422
Drug Development for Cystic Kidney Diseases
Sorin Fedeles and Ronald D. Perrone
doi : 10.2215/CJN.04910422
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease
Max C. Liebau, Erum A. Hartung and Ronald D. Perrone
doi : 10.2215/CJN.04870422
Perspectives on Drug Development in Early ADPKD
Djalila Mekahli, Hayley Womack and Neera K. Dahl
doi : 10.2215/CJN.05190422
Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD
Craig Ostroff, Ronald D. Perrone and Frank S. Czerwiec
doi : 10.2215/CJN.05360522
Conceptual Framework for Patient-Reported Outcome Measures in Clinical Trials of Skeletal Muscle Cramping Experienced in Dialysis
Michelle M. Richardson, Amanda Grandinetti, Tandrea S. Hilliard-Boone, Kenneth R. Wilund, Rebecca Wingard, Wendy L. St. Peter, Dilani Logan, Francesca Tentori, San Keller, Melissa West and Eduardo Lacson
doi : 10.2215/CJN.11980921
